South Africa confirms third monkeypox case in tourist from Switzerland
A special ward for the isolation of suspected monkeypox cases, inside the Kasturba Hospital for Infectious Diseases in Mumbai, India, in May.
Keystone / Divyakant Solanki
South Africa has confirmed a third case of monkeypox, in a 42-year-old male tourist from Switzerland, the health department of the Limpopo province said.
This content was published on
1 minute
Reuters/ts
Español
es
Sudáfrica confirma tercer caso de viruela del mono en turista de Suiza
The tourist, who is holidaying in South Africa, presented with symptoms including a rash, muscle ache and fatigue. His infection was confirmed as monkeypox by South Africa’s National Institute for Communicable Diseases.
“Three contacts have already been identified and none of them has developed signs thus far,” Limpopo health official Phophi Ramathuba said in a statement.
Monkeypox is a viral disease that causes flu-like symptoms and skin lesions. It is endemic in parts of Africa, but not South Africa.
More than 50 countries where monkeypox is not endemic have reported outbreaks of the viral disease as confirmed cases exceed 7,600. Switzerland had 140 confirmed cases as of July 8.
More
More
Swiss confirm first case of monkeypox
This content was published on
Switzerland has detected its first case of monkeypox in canton Bern, health officials said on Saturday evening.
Has your continent reached its peak or is there still potential for economic growth?
Some regions of the world are on an upward trajectory with the promise of a steadily improving future. Where do you live? And in which direction is your region or continent developing?
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
US tariffs: Pharma firms not planning job cuts in Switzerland
This content was published on
The additional investments in the US will not lead to a reduction in jobs in Switzerland. This is according to pharmaceutical giant Roche, which expects the number of employees to remain stable in the current year. The position of Novartis is similar.
Switzerland is closely monitoring three livestock diseases
This content was published on
The spread of Lumpy skin disease, Bluetongue and African swine fever are keeping Swiss veterinary authorities on the alert.
Swiss writer wins European Prize for Political Culture
This content was published on
On Saturday, the Hans Ringier Foundation awarded the 91-year-old Zurich writer Adolf Muschg the European Prize for Political Culture.
Swiss government working with firms to overcome high US tariffs
This content was published on
The Swiss delegation that travelled to Washington has returned from talks on tariffs in the United States. The negotiations are now being conducted under the aegis of the government and the federal administration, according to Seco.
WTO improves its world trade forecast thanks to Trump’s tariffs
This content was published on
The World Trade Organisation (WTO) expects world trade to grow by 0.9% this year, better than expected in April. US imports surged in the first quarter as a result of Donald Trump's tariff announcements.
Swiss gold exports might not face US tariffs after all
This content was published on
Gold exports to the United States may not be taxed after all. The White House plans to "issue an executive order in the near future to clarify misinformation regarding the taxation of gold bullion," among other things.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Monkeypox medication not authorised in Switzerland
This content was published on
Tecovirimat and the latest smallpox vaccine, which help against monkeypox, are not available in Switzerland, the NZZ am Sonntag reports.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.